Caixin
Aug 02, 2022 08:00 AM

Nanhua Bio-Medicine Co.,Ltd. Posted 3.9 Million Yuan Net Profit in First Half of 2022

Nanhua Bio-Medicine Co.,Ltd. (南华生物医药股份有限公司) (000504.SZ) reported a net profit of 3.9 million yuan in the first half of 2022, reversing a net loss of 5.1 million yuan for the same period in the previous year.

Meanwhile, the company posted 109.8 million yuan in revenue, up 62.9% year-on-year.

At the end of the reporting period, it had 562.3 million yuan in total assets and 448.1 million yuan in total liabilities, with a liability-to-asset ratio of 79.7%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin Deep Dive: Visa-Free Travel, U.S. Tariffs Drive Chinese Companies to Malaysia
00:00
00:00/00:00